BioNTech, Neon Take A Step Forward In Personalized Cancer Vaccines

 
• By Jessica Merrill

Two studies published in Nature July 5 showed that personalized cancer vaccines from BioNTech and Neon Therapeutics delivered potent immune responses in patients with melanoma. Both companies are moving forward with new studies.

T-cells attacking cancer_1200x675

More from Clinical Trials

More from R&D